People news: Biocodex USA and 3-V Biosciences

Biocodex USA hired Dr. Andres Tellez as principal, business development and strategy, responsible for in-licensing or acquiring new therapeutics to market for the US subsidiary of Biocodex, a French pharmaceutical firm.

3-V Biosciences promoted Stephen Brady to chief business officer. Brady joined the firm in 2010 as VP, corporate development, strategy & operations, with management responsibility for the company's business functions. Prior to joining 3-V, he was VP of corporate development for Proteolix. Brady also worked at Lexicon Pharmaceuticals, where he served in business development, communications and corporate legal capacities, and was a VP with Lazard Venture Advisors, a division of Lazard Freres & Co.
You must be a registered member of MMM to post a comment.

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.